Description

I help biotech companies and investors structure and maximize the value of their innovations from early development through a Value & Access strategy that bridges science and business.

With a scientific background and over ten years of experience in biotech, I combine deep product insight across technical development, regulatory affairs, non-clinical and clinical stages with a strong business mindset and strategic agility. This 360° perspective enables me to translate complex science into actionable, value-driven strategies.

Over the past five years, I have specialized in Market Access and Value Strategy for innovative therapies and drug–device combinations, helping early-stage teams and investors to shape their value story, anticipate payer and stakeholder expectations, and optimize development priorities.

My approach integrates:

Market and stakeholder potential assessment

Insight generation and strategic positioning

Definition of value propositions and competitive differentiation

Alignment of science, patient needs, and payer value

Realistic pricing and market access strategies that enhance both clinical impact and investment return

Industry field of expertise

Languages

French
Native or bilingual
English
Fluent

Workplace preferences

Can work on-site

Liège (up to 50km)

ASIT Biotech
Scientist in Production/R&D department
PHARMACEUTICALS INDUSTRY
February 2015 - October 2016 (1 year and 8 months)
Belgium
Development and improving of process for new products; planning and execution of API production (Downstream processing) at lab and pilot scale according to QC ans pre-(clinical) needs; Transfer and up-scaling to GMP facilities; writing and revison of production SOP's; Evaluation of day to day GMP scale planning, evaluation IPC decision level (GO/NO GO, important, informative...), choice and test of equipments for GMP scale production, writing technical documentation and follow up with CMO productions
Gestion de projet
ASIT Biotech (formerly Biotech Tools)
Senior Project Leader
PHARMACEUTICALS INDUSTRY
October 2016 - March 2017 (5 months)
Belgium
Responsabilities :
Coordinating the production and the analytical developement of 2 projects; Design and execution of the production protocols to improve the yield and the reliability, responsible of the compliance with the planning
Key assignements:
Development and improving of process for new products; planning and execution of API production (Downstream prossecing) at lab and the pilot scale according to QC and (pre-)clinical needs; Choice and test of equipment for GMP scale production
Gestion de projet
Pharmaxess Consulting
Value & Access Strategy Consultant
CONSULTING AND AUDITS
September 2024 - Today (1 year and 10 months)
Belgium
Advise biotech companies on market access strategy, value communication, and competitive positioning. Conduct pricing and market access analyses across EU and US markets, including payer segmentation, CMS reimbursement pathways, and competitive price benchmarking. Develop evidence generation and value demonstration roadmaps, integrating payer, clinician, and patient insights to guide development decisions. Provide strategic guidance to leadership and investors, articulating how scientific differentiation translates into market and reimbursement value. Participate in and provide strategic input to the translation and adaptation of French HTA dossiers into Belgian submissions, ensuring alignment with local frameworks and payer evidence needs.
Pricing Market Access life sciences investment